NCT06695572View on ClinicalTrials.gov

Clinical Study to Evaluate the Food Effect of CKD-383 0.5/10/1000mg in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 6, 2024

Primary Completion Date

December 7, 2024

Study Completion Date

December 13, 2024

Conditions
Type 2 Diabetes Mellitus (T2DM)
Interventions
DRUG

CKD-383

QD, PO

Trial Locations (1)

07590

Bumin Hospital, Gangseo-gu

Sponsors
All Listed Sponsors
collaborator

Bumin Hospital

UNKNOWN

lead

Chong Kun Dang Pharmaceutical

INDUSTRY